187 related articles for article (PubMed ID: 18535191)
1. Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults.
Adler AI; Shine BS; Chamnan P; Haworth CS; Bilton D
Diabetes Care; 2008 Sep; 31(9):1789-94. PubMed ID: 18535191
[TBL] [Abstract][Full Text] [Related]
2. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
[TBL] [Abstract][Full Text] [Related]
3. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
Putman MS; Norris AW; Hull RL; Rickels MR; Sussel L; Blackman SM; Chan CL; Ode KL; Daley T; Stecenko AA; Moran A; Helmick MJ; Cray S; Alvarez JA; Stallings VA; Tuggle KL; Clancy JP; Eggerman TL; Engelhardt JF; Kelly A
Diabetes; 2023 Jun; 72(6):677-689. PubMed ID: 37125945
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al.
Olesen HV; Drevinek P; Gulmans VA; Hatziagorou E; Jung A; Mei-Zahav M; Stojnic N; Thomas M; Zolin A;
J Cyst Fibros; 2020 Mar; 19(2):321-327. PubMed ID: 31680042
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D Status and Risk of Cystic Fibrosis-Related Diabetes: A Retrospective Single Center Cohort Study.
Peng Y; Wu M; Alvarez JA; Tangpricha V
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836301
[TBL] [Abstract][Full Text] [Related]
6. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
Putman MS; Norris AW; Hull RL; Rickels MR; Sussel L; Blackman SM; Chan CL; Ode KL; Daley T; Stecenko AA; Moran A; Helmick MJ; Cray S; Alvarez JA; Stallings VA; Tuggle KL; Clancy JP; Eggerman TL; Engelhardt JF; Kelly A
Diabetes Care; 2023 Jun; 46(6):1112-1123. PubMed ID: 37125948
[TBL] [Abstract][Full Text] [Related]
7. Diabetes as a determinant of mortality in cystic fibrosis.
Chamnan P; Shine BS; Haworth CS; Bilton D; Adler AI
Diabetes Care; 2010 Feb; 33(2):311-6. PubMed ID: 19918014
[TBL] [Abstract][Full Text] [Related]
8. Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes.
Sims EJ; Green MW; Mehta A
Diabetes Care; 2005 Jul; 28(7):1581-7. PubMed ID: 15983304
[TBL] [Abstract][Full Text] [Related]
9. The Potential Causes of Cystic Fibrosis-Related Diabetes.
Coderre L; Debieche L; Plourde J; Rabasa-Lhoret R; Lesage S
Front Endocrinol (Lausanne); 2021; 12():702823. PubMed ID: 34394004
[TBL] [Abstract][Full Text] [Related]
10. The development of diabetes among Danish cystic fibrosis patients over the last two decades.
Knudsen KB; Mathiesen ER; Eriksen V; Skov M; Nielsen KG; Johannesen J; Pressler T
Pediatr Diabetes; 2015 May; 16(3):219-26. PubMed ID: 24891216
[TBL] [Abstract][Full Text] [Related]
11. Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits.
Aksit MA; Pace RG; Vecchio-Pagán B; Ling H; Rommens JM; Boelle PY; Guillot L; Raraigh KS; Pugh E; Zhang P; Strug LJ; Drumm ML; Knowles MR; Cutting GR; Corvol H; Blackman SM
J Clin Endocrinol Metab; 2020 May; 105(5):1401-15. PubMed ID: 31697830
[TBL] [Abstract][Full Text] [Related]
12. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
[TBL] [Abstract][Full Text] [Related]
13. Microvascular complications in cystic fibrosis-related diabetes.
Schwarzenberg SJ; Thomas W; Olsen TW; Grover T; Walk D; Milla C; Moran A
Diabetes Care; 2007 May; 30(5):1056-61. PubMed ID: 17322485
[TBL] [Abstract][Full Text] [Related]
14. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
[TBL] [Abstract][Full Text] [Related]
15. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors of paediatric cystic fibrosis-related diabetes.
Perrem L; Stanojevic S; Solomon M; Carpenter S; Ratjen F
J Cyst Fibros; 2019 Nov; 18(6):874-878. PubMed ID: 31072797
[TBL] [Abstract][Full Text] [Related]
17. Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex.
Lewis C; Blackman SM; Nelson A; Oberdorfer E; Wells D; Dunitz J; Thomas W; Moran A
Am J Respir Crit Care Med; 2015 Jan; 191(2):194-200. PubMed ID: 25479583
[TBL] [Abstract][Full Text] [Related]
18. Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients.
Kutney K; Donnola SB; Flask CA; Gubitosi-Klug R; O'Riordan M; McBennett K; Sferra TJ; Kaminski B
World J Hepatol; 2019 Dec; 11(12):761-772. PubMed ID: 31966908
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.
Limoli DH; Yang J; Khansaheb MK; Helfman B; Peng L; Stecenko AA; Goldberg JB
Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):947-53. PubMed ID: 26993289
[TBL] [Abstract][Full Text] [Related]
20. Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis.
Blackman SM; Hsu S; Vanscoy LL; Collaco JM; Ritter SE; Naughton K; Cutting GR
J Clin Endocrinol Metab; 2009 Apr; 94(4):1302-9. PubMed ID: 19126627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]